Cytokinetics, Inc. (CYTK)
77.09
+0.25
(+0.33%)
USD |
NASDAQ |
Aug 24, 16:00
77.09
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Total Liabilities (Quarterly) : 2.098B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.098B |
| March 31, 2026 | 2.100B |
| December 31, 2025 | 2.084B |
| September 30, 2025 | 1.958B |
| June 30, 2025 | 1.594B |
| March 31, 2025 | 1.530B |
| December 31, 2024 | 1.537B |
| September 30, 2024 | 1.450B |
| June 30, 2024 | 1.415B |
| March 31, 2024 | 1.204B |
| December 31, 2023 | 1.211B |
| September 30, 2023 | 1.179B |
| June 30, 2023 | 1.113B |
| March 31, 2023 | 1.119B |
| December 31, 2022 | 1.123B |
| September 30, 2022 | 1.092B |
| June 30, 2022 | 660.30M |
| March 31, 2022 | 739.99M |
| December 31, 2021 | 597.46M |
| September 30, 2021 | 578.52M |
| June 30, 2021 | 547.81M |
| March 31, 2021 | 509.22M |
| December 31, 2020 | 420.42M |
| September 30, 2020 | 324.51M |
| June 30, 2020 | 310.58M |
| Date | Value |
|---|---|
| March 31, 2020 | 302.29M |
| December 31, 2019 | 300.75M |
| September 30, 2019 | 207.26M |
| June 30, 2019 | 203.11M |
| March 31, 2019 | 195.24M |
| December 31, 2018 | 185.24M |
| September 30, 2018 | 178.21M |
| June 30, 2018 | 172.07M |
| March 31, 2018 | 180.33M |
| December 31, 2017 | 184.97M |
| September 30, 2017 | 179.28M |
| June 30, 2017 | 165.63M |
| March 31, 2017 | 169.99M |
| December 31, 2016 | 75.78M |
| September 30, 2016 | 73.44M |
| June 30, 2016 | 57.42M |
| March 31, 2016 | 55.31M |
| December 31, 2015 | 46.65M |
| September 30, 2015 | 34.90M |
| June 30, 2015 | 37.84M |
| March 31, 2015 | 38.06M |
| December 31, 2014 | 40.90M |
| September 30, 2014 | 13.56M |
| June 30, 2014 | 17.45M |
| March 31, 2014 | 21.10M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 141.52M |
| Ionis Pharmaceuticals, Inc. | 2.555B |
| Bristol Myers Squibb Co. | 65.32B |
| Gilead Sciences, Inc. | 37.62B |
| Rigel Pharmaceuticals, Inc. | 95.64M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.925B |
| Shareholders Equity (Quarterly) | -173.49M |
| Debt to Equity Ratio | -7.324 |
| Current Ratio | 6.661 |
| Net Debt Paydown Yield | -0.81% |